Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 08/1/14 → 07/31/15 |
Funding
- Biogen IDEC: $15,465.00
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB003 in Subjects with Relapsing Forms of Multiple Sclerosis When Used Concurrently
- Hojnacki, David (PI)
Project: Research